Central Institute of Mental Health Researchers Illuminate Research in Tetrahydrocannabinol (Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers).

The article explores the dose-dependent effects of cannabidiol (CBD) and delta-9-tetrahydrocannabinol (D9-THC) on serum anandamide and related compounds. Topics discussed include the impact of different dosages of CBD and D9-THC on endocannabinoid levels, the combined administration of these cannabinoids, and the potential implications for dosage guidelines and therapeutic use in conditions like schizophrenia.